Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | K G NATH PHARMA AND SURGICALS | 1 | ₹4,950 |
| 2 | Schedule 2 | HOPE HEALTH CONCERNS PRIVATE LIMITED | 1 | ₹28,770 |
| 3 | Schedule 3 | K G NATH PHARMA AND SURGICALS | 1 | ₹5,832 |
| 4 | Schedule 4 | M/S. K.K.ENTERPRISES | 1 | ₹10,200 |
| 5 | Schedule 5 | M/S. K.K.ENTERPRISES | 1 | ₹5,880 |
Tender Value
₹87,339.42
EMD Value
Exempted
Closing Date
28 Feb 2025, 1:00 pmClosed
Clobetasol 0.05 percent plus Salicylic Acid 3.50 percent Oint 20 gms
Mandelic Acid 2 Percent salicylic acid 1 percent azeliaic acid 0.5 percent foaming face wash tube of 60 ml
Lulicanazole 1 percent cream tube of 30 gm
Urea 10 percent plus Lactic Acid 10 Percent plus propylene glycol 10 percent plus light liquid paraffin 10 percent in cream base Moistuerx 75 gm
2 propanol and 1 prorpanol Macetronium Ethysulphate 0.2 percent 45 gmsb by 30mgms
ECG recording paper 50 mm 30 mtr long 210m into 20 m 70 GSM 18 mm
Ryles tube size 18 for for the purpose of artificial feeding and gastric aspiration
Clotrimazole mouth paint 1 percent bottle of 15 ml for use of mouth ulcer patients
ventillation circuit paed for the use of intubated patients in ICU
T Piece in three size for oxygen delivery to patients in ICU
Morphine 15 mg 1ml inj to use as a analgesics and sedative
Oxytocin 5 unit per 1.0 ml amp inj for induction of labour to stimulate uterine contraction
Glycopyrrolate 0.2 mg per ml 1 ml inj to use in intensive care unit for patients
7491230
GEM/2025/B/5922386
Two Packet Bid
Clobetasol 0.05 percent plus Salicylic Acid 3.50 percent Oint
30 days
East Khasi hills
Item wise evaluation
BOQ
8 documents required · 8 mandatory
1 yrs
₹31
10%
Exempted
28 Feb 2025
7 Feb 2025
28 Feb 2025
Clobetasol 0.05 percent plus Salicylic Acid 3.50 percent Oint 20 gms
Mandelic Acid 2 Percent salicylic acid 1 percent azeliaic acid 0.5 percent foaming face wash tube of 60 ml
Lulicanazole 1 percent cream tube of 30 gm
Urea 10 percent plus Lactic Acid 10 Percent plus propylene glycol 10 percent plus light liquid paraffin 10 percent in cream base Moistuerx 75 gm
2 propanol and 1 prorpanol Macetronium Ethysulphate 0.2 percent 45 gmsb by 30mgms
ECG recording paper 50 mm 30 mtr long 210m into 20 m 70 GSM 18 mm
Ryles tube size 18 for for the purpose of artificial feeding and gastric aspiration
Clotrimazole mouth paint 1 percent bottle of 15 ml for use of mouth ulcer patients
ventillation circuit paed for the use of intubated patients in ICU
T Piece in three size for oxygen delivery to patients in ICU
Morphine 15 mg 1ml inj to use as a analgesics and sedative
Oxytocin 5 unit per 1.0 ml amp inj for induction of labour to stimulate uterine contraction
Glycopyrrolate 0.2 mg per ml 1 ml inj to use in intensive care unit for patients
Clobetasol 0.05 percent plus Salicylic Acid 3.50 percent Oint 20 gms
Mandelic Acid 2 % salicylic acid 1% azeliaic acid 0.5 % face wash 60 ml
Lulicanazole 1 percent cream tube of 30 gm
Urea Lactic Acid 10 % propylene glycol 10 % l paraffin cream 75 gm
2 propanol 1 prorpanol Macetronium Ethysulphate 0.2 % 45 gms 30mgms
ECG recording paper 50 mm 30 mtr 210m into 20 m 70 GSM 18 mm
Ryles tube size 18
Clotrimazole mouth paint 1 percent bottle of 15 ml
ventillation circuit paed
T Piece in three size
Morphine 15 mg 1ml inj
Oxytocin 5 unit per 1.0 ml amp inj
Glycopyrrolate 0.2 mg per ml 1 ml inj
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7491230.pdf
GEM_BID
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
cllo_2025-02-07-12-03-38_278071fe19ad97def7eaa7838d574799.pdf
BOQ
clobetasol_sample_2025-02-07-12-03-38_af2f4e11e0540339227a4aee5b0090c8.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .